ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.

‘Live tissue training’, using an anaesthetised live animal substituted ... analysed by themselves or compared with alternative modalities simulating surgery on human patients, evaluating LTT ...